Ubs Group Ag Medpace Holdings, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 61,951 shares of MEDP stock, worth $22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,951

Previous 69,766 11.2%

Holding current value

$22 Million

Previous $28.7 Million 28.1%

% of portfolio

0.0%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$320.58 - $457.29 $2.51 Million - $3.57 Million	-7,815 Reduced 11.2%	61,951 $20.7 Million
Q2 2024 Aug 13, 2024	BUY	$372.0 - $424.34 $6.87 Million - $7.84 Million	18,471 Added 36.01%	69,766 $28.7 Million
Q1 2024 May 13, 2024	BUY	$284.87 - $413.31 $10.8 Million - $15.7 Million	38,004 Added 285.94%	51,295 $20.7 Million
Q4 2023 Feb 09, 2024	BUY	$227.52 - $312.68 $512,830 - $704,780	2,254 Added 20.42%	13,291 $4.07 Million
Q3 2023 Nov 09, 2023	SELL	$233.98 - $281.67 $111,608 - $134,356	-477 Reduced 4.14%	11,037 $2.67 Million
Q2 2023 Aug 11, 2023	BUY	$187.26 - $240.17 $75,278 - $96,548	402 Added 3.62%	11,514 $2.77 Million
Q1 2023 May 12, 2023	SELL	$174.31 - $239.52 $2.23 Million - $3.06 Million	-12,784 Reduced 53.5%	11,112 $2.09 Million
Q4 2022 Feb 08, 2023	BUY	$153.06 - $226.57 $2.37 Million - $3.51 Million	15,513 Added 185.05%	23,896 $5.08 Million
Q3 2022 Nov 10, 2022	BUY	$145.13 - $182.49 $125,247 - $157,488	863 Added 11.48%	8,383 $1.32 Million
Q2 2022 Aug 10, 2022	SELL	$130.2 - $168.03 $699,304 - $902,489	-5,371 Reduced 41.66%	7,520 $1.13 Million
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $3.94 Million - $6.08 Million	-28,348 Reduced 68.74%	12,891 $2.11 Million
Q4 2021 Feb 14, 2022	BUY	$182.74 - $227.9 $3.82 Million - $4.76 Million	20,895 Added 102.71%	41,239 $8.98 Million
Q3 2021 Nov 15, 2021	BUY	$170.18 - $198.21 $1.72 Million - $2 Million	10,106 Added 98.71%	20,344 $3.85 Million
Q2 2021 Aug 13, 2021	SELL	$158.62 - $194.3 $2.63 Million - $3.22 Million	-16,552 Reduced 61.78%	10,238 $1.81 Million
Q1 2021 May 12, 2021	SELL	$132.02 - $168.26 $635,808 - $810,340	-4,816 Reduced 15.24%	26,790 $4.4 Million
Q4 2020 Feb 11, 2021	BUY	$109.38 - $149.19 $610,559 - $832,778	5,582 Added 21.45%	31,606 $4.4 Million
Q3 2020 Nov 12, 2020	BUY	$92.95 - $130.61 $475,811 - $668,592	5,119 Added 24.49%	26,024 $2.91 Million
Q2 2020 Jul 31, 2020	BUY	$68.08 - $95.68 $1.17 Million - $1.65 Million	17,202 Added 464.54%	20,905 $1.94 Million
Q1 2020 May 01, 2020	SELL	$61.71 - $101.95 $87,689 - $144,870	-1,421 Reduced 27.73%	3,703 $272,000
Q4 2019 Feb 14, 2020	BUY	$70.08 - $84.64 $40,436 - $48,837	577 Added 12.69%	5,124 $431,000
Q3 2019 Nov 14, 2019	BUY	$62.38 - $85.89 $101,180 - $139,313	1,622 Added 55.45%	4,547 $382,000
Q2 2019 Aug 14, 2019	SELL	$53.64 - $65.42 $58,092 - $70,849	-1,083 Reduced 27.02%	2,925 $191,000
Q1 2019 May 14, 2019	SELL	$49.38 - $70.58 $836,299 - $1.2 Million	-16,936 Reduced 80.86%	4,008 $237,000
Q4 2018 Feb 14, 2019	BUY	$46.97 - $63.98 $117,331 - $159,822	2,498 Added 13.54%	20,944 $1.11 Million
Q3 2018 Nov 14, 2018	SELL	$43.25 - $63.74 $9.83 Million - $14.5 Million	-227,171 Reduced 92.49%	18,446 $1.11 Million
Q2 2018 Aug 14, 2018	SELL	$34.03 - $45.46 $2.64 Million - $3.53 Million	-77,690 Reduced 24.03%	245,617 $10.6 Million
Q1 2018 May 15, 2018	BUY	$32.03 - $39.05 $10 Million - $12.2 Million	312,420 Added 2869.66%	323,307 $11.3 Million
Q4 2017 Feb 14, 2018	BUY	$32.46 - $38.31 $194 - $229	6 Added 0.06%	10,887 $395,000
Q3 2017 Nov 14, 2017	BUY	$27.43 - $33.11 $239,957 - $289,646	8,748 Added 410.13%	10,881 $347,000
Q2 2017 Aug 14, 2017	BUY	N/A	948 Added 80.0%	2,133 $62,000
Q1 2017 Nov 14, 2017	BUY	N/A	1,185	1,185 $36,000

Others Institutions Holding MEDP

# of Institutions

616

Shares Held

25M

Call Options Held

42.8K

Put Options Held

207K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $11B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account